Danaher logged a -0.8% change during today's afternoon session, and is now trading at a price of $190.44 per share. On average, analysts give it a target price of $246.83.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The large-cap company is based in the United States. Danaher currently returns an annual dividend yield of 0.6%.
What to Consider if You Are Thinking of Buying Danaher:
-
Danaher has moved -21.0% over the last year.
-
DHR has a forward P/E ratio of 24.3 based on its EPS guidance of 7.83.
-
Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of 14.7%.
-
The company has a price to earnings growth (PEG) ratio of -19.11.
-
Its Price to Book (P/B) ratio is 2.69
Danaher Has Generally Positive Cash Flows
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 8,519,000 | 1,222,000 | 7,297,000 | -0.95 |
| 2022 | 8,519,000 | 1,152,000 | 7,367,000 | 4.29 |
| 2021 | 8,358,000 | 1,294,000 | 7,064,000 | 30.24 |
| 2020 | 6,215,000 | 791,000 | 5,424,000 | 63.57 |
| 2019 | 3,952,000 | 636,000 | 3,316,000 | -3.55 |
| 2018 | 4,022,000 | 584,000 | 3,438,000 |
Danaher's free cash flows are strong in the aggregate, since they average out to $5.65 Billion over the last 6 years. But they are highly variable since their coefficient of variability is 182.3%. The compounded average growth rate for this period stands at 13.4%.
